Orthofix International (OFIX) Tops Q4 EPS by 25c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
February 26, 2021 7:00 AM ESTFourth quarter net sales of $117.6 million, within 3% of our 2019 results US Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performance Strong cash flow performance in the quarter, free cash flow of $17.9 million FITBONE® intramedullary lengthening and deformity system receives FDA clearance for pediatric indication
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2020. Net sales for... More
